Two Sigma Securities
DMK

Two Sigma Securities’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Two Sigma Securities’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-18,059
Closed -$12.6K – 3862
2023
Q4 		$12.6K Sell
18,059
-11,649
-39% -$6.76K ﹤0.01% 2789
2023
Q3 		$20.5K Buy
+29,708
New +$38K ﹤0.01% 2566
2023
Q2 		– Sell
-352
Closed -$2.85K – 3502
2023
Q1 		$2.85K Sell
352
-48
-12% -$638 ﹤0.01% 2546
2022
Q4 		$4.74K Sell
400
-173
-30% -$1.98K ﹤0.01% 2457
2022
Q3 		$8K Sell
573
-765
-57% -$19.7K ﹤0.01% 2435
2022
Q2 		$47K Buy
+1,338
New +$41.8K ﹤0.01% 1856
2022
Q1 		– Sell
-327
Closed -$14K – 2635
2021
Q4 		$14K Buy
+327
New +$20.4K ﹤0.01% 1449
2018
Q3 		– Sell
-199
Closed -$45K – 3127
2018
Q2 		$45K Buy
+199
New +$53.3K ﹤0.01% 2521
2018
Q1 		– Sell
-240
Closed -$74K – 3026
2017
Q4 		$74K Buy
+240
New +$79K ﹤0.01% 1486
2017
Q3 		– Sell
-200
Closed -$73K – 1281
2017
Q2 		$73K Buy
+200
New +$59.9K 0.01% 684

Other funds holding DMK

Clear Point Advisors
Clear Point Advisors Melville, New York $113M AUM 15% 1-Year Est. Return
Old Point Trust & Financial Services N A
Old Point Trust & Financial Services N A Newport News, Virginia $329M AUM 22.88% 1-Year Est. Return

Two Sigma Securities's DMK Position: Q1 2024 in Review

Two Sigma Securities sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q1 2024, closing a stake of 18,059 shares — an estimated $12.6K sold.

Two Sigma Securities first reported a position in DMK in Q2 2017 and held it in 10 quarters. The position peaked at $74K in Q4 2017. 3 funds tracked by Wall St. Rank hold DMK as of Q1 2024.

  • Two Sigma Securities reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q1 2024 after selling out during the quarter.
  • Two Sigma Securities sold 18,059 DMK Pharmaceuticals Corporation Common Stock shares in Q1 2024, an estimated $12.6K.
  • Two Sigma Securities first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q2 2017 and held it in 10 quarters.
  • Two Sigma Securities's DMK Pharmaceuticals Corporation Common Stock position peaked at $74K in Q4 2017.
  • 3 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q1 2024.

Based on Two Sigma Securities's 13F filing for Q1 2024, filed 15 May 2024.